DataString Consulting Company Logo
DataString Consulting Company Logo
Brain Imaging Devices Market
Home»Top Market Reports»Brain Imaging Devices Market

Brain Imaging Devices Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801028, Published - December 2024

Segmented in Device Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG)), Technology (Functional, Structural, Molecular), Application, End-user and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Brain Imaging Devices Market Outlook

Brain imaging technology is changing the field of medicine in ways and opening up exciting possibilities, in healthcare innovation. The market, for Brain imaging devices was estimated at $6.4 billion in 2024. It is anticipated to increase to $10.2 billion by 2030 with projections indicating a growth to around $15.1 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 8.14% over the forecast period. The advanced devices have the power to completely transform the way we practice medicine by providing extraordinary insights into the intricate workings of the human brain—the most complex biological structure known to us.


Cutting edge diagnostic tools provide healthcare providers and researchers with visual representations of brain structures and functions to aid in diagnosing and treating neurodegenerative diseases, psychiatric disorders and brain injuries. Recent trends show an increase in their usage driven by advancements in AI and machine learning technologies and the growing incidence of neurological conditions. Brain imaging equipment plays a role not just in diagnosing and treating illnesses but also serves as essential instruments, for neurological and psychological research.


Market Size Forecast & Key Insights

2019
$6.4B2024
2029
$13.9B2034

Absolute Growth Opportunity = $7.6B

The Brain Imaging Devices market is projected to grow from $6.4 billion in 2024 to $13.9 billion in 2034. This represents a CAGR of 8.14%, reflecting rising demand across Clinical Diagnosis, Research and Development and Screening and Monitoring.

The Brain Imaging Devices market is set to add $7.6 billion between 2024 and 2034, with manufacturer targeting Computed Tomography (CT) & Positron Emission Tomography (PET) Device Type projected to gain a larger market share.

With Advancements in neurological research, and Rise in neurological disorders, Brain Imaging Devices market to expand 119% between 2024 and 2034.

Opportunities in the Brain Imaging Devices Market

Personalized Medicine in Neurology

Brain scanners can play a role in personalized healthcare services with a special focus on neurology by customizing treatment approaches according to the unique brain scan findings of each patient to enhance treatment effectiveness and drive the need, for cutting edge imaging technology.

AI-Integrated Imaging and TeleNeuroImaging

The use of Artificial Intelligence in brain imaging tools is a developing trend in the medical field. By leveraging AIs ability to process amounts of data efficiently and accurately the diagnosis of various brain conditions can be made more precise and quicker. This advancement holds the potential to reshape the market, for brain imaging devices significantly.

Access to brain imaging from a distance could revolutionize the way neurological care is provided – in regions without enough specialist resources available for patients in need of such services. TeleNeuroImaging serves as a link connecting patients located far away with neurologists and sets the stage for the expansion of brain imaging technology, within the market.

Growth Opportunities in North America and Europe

Europe Outlook

Europe ranks as the largest market for brain imaging devices thanks to its generous healthcare investment and well established healthcare facilities alongside heightened research endeavors in neurological disorders area. Key market shares are held by nations like Germany France and the UK where prospects lie in creating portable and wireless brain imaging tools, for point of care provisions.

North America Outlook

North America stands out as a center for medical technology in the field of Brain Imaging Devices market with the United States taking the lead position prominently amid a rising elderly population and an uptick in neurological disorders prevalence seen in recent times here. The markets growth is attributed to the presence of established industry leaders and robust research and development undertakings within this region. Strict regulatory standards and substantial healthcare spending play a role in maintaining product quality and ensuring accessibility, to these devices. In todays market environment whichs fiercely competitive for medical equipment and services like PET scans and MRI machines are at the forefront due, to their superior diagnostic capabilities.

North America Outlook

North America stands out as a center for medical technology in the field of Brain Imaging Devices market with the United States taking the lead position prominently amid a rising elderly population and an uptick in neurological disorders prevalence seen in recent times here. The markets growth is attributed to the presence of established industry leaders and robust research and development undertakings within this region. Strict regulatory standards and substantial healthcare spending play a role in maintaining product quality and ensuring accessibility, to these devices. In todays market environment whichs fiercely competitive for medical equipment and services like PET scans and MRI machines are at the forefront due, to their superior diagnostic capabilities.

Europe Outlook

Europe ranks as the largest market for brain imaging devices thanks to its generous healthcare investment and well established healthcare facilities alongside heightened research endeavors in neurological disorders area. Key market shares are held by nations like Germany France and the UK where prospects lie in creating portable and wireless brain imaging tools, for point of care provisions.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, Canada are expected to grow at 5.9% to 8.5% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 7.8% to 10.2% CAGR

Market Analysis Chart

The rise in cases of conditions like Alzheimers disease and Parkinsons disease is leading to a higher demand for brain imaging tools in the market while advancements in technology within neuroscience and radiology are also playing a significant role, in driving this growth forward.

Recent Developments and Technological Advancement

March 2024

NeuroCorp has released its cutting edge Neuro 360 device which allows for real time monitoring of brain activity using EEG technology.

June 2024

Brain Dynamics unveiled their groundbreaking brain scanner named BioPlexus that provides detailed imaging with ultra high resolution, through PET and CT technologies.

November 2024

MindTrek Inc introduced the SpectraView. An updated MRI system enhancing resolution and signal strength, for brain imaging.

The Brain Imaging Devices market has seen advancements due to increased efforts in research and development by major companies aiming to create cutting edge technologies for better diagnosis and treatment methods. There is a trend in the market with the fast growth of neuroimaging techniques driven largely by the emergence of hybrid imaging machines, like PET/MRI devices.

Impact of Industry Transitions on the Brain Imaging Devices Market

As a core segment of the Medical Device industry, the Brain Imaging Devices market develops in line with broader industry shifts. Over recent years, transitions such as Adoption of AI in Brain Imaging and Shift Toward Portable Brain Imaging Devices have redefined priorities across the Medical Device sector, influencing how the Brain Imaging Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Adoption of AI in Brain Imaging:

The use of Artificial Intelligence is greatly changing the market for brain imaging devices by boosting the efficiency and accuracy of brain scans to improve the specificity and personalization of diagnosis and treatment processes significantly. AI technology can identify brain changes that might go unnoticed, by human clinicians, l which results in earlier and more accurate diagnoses being made. Additionally it is reducing the duration needed for examining brain scans allowing for medical interventions to take place.

2

Shift Toward Portable Brain Imaging Devices:

The arrival of brain imaging gadgets marks another important shift, in this industry sector. They are user friendly devices intended to be brought directly to the patients location – be it a hospital room or an ambulance.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Brain Imaging Devices market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Advancements in Neurological Research, and Evolution of Artificial Intelligence

Recent progress in neuroscience has also sparked an increase in the need for brain imaging tools as researchers seek to gain deeper insights, into brain functions and unravel the mysteries of neurological conditions through innovative imaging methods that offer detailed views of brain functions.
The use of Artificial Intelligence in imaging has also brought significant changes to the market, for brain imaging devices. Clever use of AI technology elevates the effectiveness of these devices by enhancing image quality and accuracy while also minimizing errors and aiding in the forecast and prevention of brain related ailments.
With the aging of the worlds inhabitants comes an increase in neurological conditions such as Alzheimers disease and Parkinsons disease as well as stroke cases on the rise too in recent times leading to a surge in demand for precise diagnosis and therapy options thus boosting the requirement, for advanced brain imaging equipment.

Restraint: High Cost of Equipment

Brain scanning tools like MRI and CT scans come with a price tag that hinders their widespread use in low and middle income countries due to both the initial purchase cost and ongoing expenses, for maintenance and skilled staff required for operation. This financial obstacle often deters healthcare providers from adopting these technologies. Slows down market expansion.

Challenge: Stringent Regulatory Policies

The rules surrounding brain imaging devices are quite intricate and rigorous requiring them to undergo a series of approvals from organizations such as the FDA in the United States and the EMA in Europe before they can be made available for sale, on the market.

Supply Chain Landscape

Material Sourcing

General Electric Company

Siemens AG

Component Manufacturing

Koninklijke Philips N.V.

Hitachi Ltd

Device Assembly
Canon Medical Systems Corporation / Medtronic Plc
End User Application and Sales
Hospitals / Diagnostic Imaging Centers / Neurology Centers
Material Sourcing

General Electric Company

Siemens AG

Component Manufacturing

Koninklijke Philips N.V.

Hitachi Ltd

Device Assembly

Canon Medical Systems Corporation

Medtronic Plc

End User Application and Sales

Hospitals

Diagnostic Imaging Centers

Neurology Centers

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeadingProvidersProvider Strategies
Neurological Diagnostics
Healthcare & Medicine
GE Healthcare, Siemens Healthineers
Product innovation, R&D investment, Strategic partnerships
Clinical Trials
Pharmaceuticals
Philips Healthcare, Hitachi Medical Systems
User-friendly designs, Regulatory compliance, Extensive customer service
Research and Development
Education, Research Institutes
Natus Medical, Canon Medical Systems
Technological advancement, Collaboration with academic institutes, Enhancement of imaging capabilities
Veterinary Diagnostics
Veterinarian
Sedecal, VetRay
Adaptation of human brain imaging technology for animals, Affordable pricing, Extend service networks

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Brain Imaging Devices market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Brain Imaging Devices in Research and Development, Screening and Monitoring and Clinical Diagnosis

Research and Development

Brain imaging tools play a role in studying how the brain works and the connections between neural pathways for research purposes. They are essential for neuroscience studies, d research and the creation of new medications. Research pioneers such, as Canon Medical Systems utilize cutting edge technologies to improve efficiency and produce high quality images that boost research progress.

Screening and Monitoring

Hospitals and diagnostic centers are utilizing brain imaging technology frequently to observe and manage patients’ health conditions over time efficiently. This method aids healthcare providers in monitoring disease advancement and treatment efficacy while also examining brain functions and any potential irregularities over a period. Philips Healthcare stands out as a player, in the market offering advanced devices that leverage AI for automated image analysis and enhanced patient monitoring processes.

Clinical Diagnosis

Brain scanning tools like MRI and CT scanners play a role in the field of medicine for diagnosing brain related issues in clinical settings by identifying any structural irregularities in the brain such as tumors or strokes and allowing prompt treatment interventions to take place when needed. Major industry players such, as GE Healthcare and Siemens Healthineers are known for offering imaging technology that not only provides high quality scans but also prioritizes patient comfort and rapid diagnosis processes.

Brain Imaging Devices vs. Substitutes:
Performance and Positioning Analysis

Brain imaging machines such as MRI and CT scanners are highly effective in providing views of the brains structure and functions and are superior to methods like EEG in this regard. Their popularity is, on the rise as the aging population grows and technology continues to advance.

Brain Imaging Devices
  • Functional Near Infrared Spectroscopy (fNIRS) /
  • Electroencephalography (EEG)
    High precision in detecting brain abnormalities, Non-invasive procedure
    High cost, Limited availability in rural areas
    Non-invasive, relatively safe procedures
    Limited resolution, potential for misinterpretation due to complex data analysis

Brain Imaging Devices vs. Substitutes:
Performance and Positioning Analysis

Brain Imaging Devices

  • High precision in detecting brain abnormalities, Non-invasive procedure
  • High cost, Limited availability in rural areas

Functional Near Infrared Spectroscopy (fNIRS) / Electroencephalography (EEG) / Magnetoencephalography (MEG)

  • Non-invasive, relatively safe procedures
  • Limited resolution, potential for misinterpretation due to complex data analysis

Brain imaging machines such as MRI and CT scanners are highly effective in providing views of the brains structure and functions and are superior to methods like EEG in this regard. Their popularity is, on the rise as the aging population grows and technology continues to advance.

Loading...

Research Methodology

This market research methodology defines the Brain Imaging Devices market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Brain Imaging Devices across Hospitals, Diagnostic Centers, and Research Institutes Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Material Sourcing, Component Manufacturing, and Device Assembly. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Brain Imaging Devices segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Material Sourcing (General Electric Company, Siemens AG), Component Manufacturing (Koninklijke Philips N.V., Hitachi Ltd), and Device Assembly. Our parallel substitute analysis examines Functional Near Infrared Spectroscopy (fNIRS), Electroencephalography (EEG), and Magnetoencephalography (MEG), highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Brain Imaging Devices market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Brain Imaging Devices Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 6.9 billion
Revenue Forecast in 2034USD 13.9 billion
Growth RateCAGR of 8.14% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20246.4 billion
Growth OpportunityUSD 7.6 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20246.4 billion USD
Market Size 20278.1 billion USD
Market Size 20299.4 billion USD
Market Size 203010.2 billion USD
Market Size 203413.9 billion USD
Market Size 203515.1 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredDevice Type, Technology, Application, End-user
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledSiemens Healthineers, GE Healthcare, Koninklijke Philips N.V, Canon Medical Systems Corporation, Hitachi Ltd, Neusoft Medical Systems Co. Ltd, Mindray Medical International Ltd, Fujifilm Holdings Corporation, Esaote SpA, Planmeca OY, Samsung Medison Co. Ltd and Shimadzu Corporation
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Brain Imaging Devices Market Size, Opportunities & Strategic Insights, by Device Type

4.1Magnetic Resonance Imaging (MRI)
4.2Computed Tomography (CT)
4.3Positron Emission Tomography (PET)
4.4Electroencephalography (EEG)
Chapter 5

Brain Imaging Devices Market Size, Opportunities & Strategic Insights, by Technology

5.1Functional
5.2Structural
5.3Molecular
Chapter 6

Brain Imaging Devices Market Size, Opportunities & Strategic Insights, by Application

6.1Tumor Detection
6.2Epilepsy
6.3Alzheimer's
6.4Stroke
6.5Other Neurological Disorders
Chapter 7

Brain Imaging Devices Market Size, Opportunities & Strategic Insights, by End-user

7.1Hospitals
7.2Diagnostic Centers
7.3Research Institutes
7.4Ambulatory Surgical Centers
Chapter 8

Brain Imaging Devices Market, by Region

8.1North America Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Brain Imaging Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Siemens Healthineers
9.2.2GE Healthcare
9.2.3Koninklijke Philips N.V
9.2.4Canon Medical Systems Corporation
9.2.5Hitachi Ltd
9.2.6Neusoft Medical Systems Co. Ltd
9.2.7Mindray Medical International Ltd
9.2.8Fujifilm Holdings Corporation
9.2.9Esaote SpA
9.2.10Planmeca OY
9.2.11Samsung Medison Co. Ltd
9.2.12Shimadzu Corporation